Health Condition 1: B358- Other dermatophytoses
Conditions
Interventions
Intervention1: 50 millesimal scale single-dose: After detail case taking the 50 millesimal scale single-dose approach will be given after randomization.
duration of study 18 months.
Control Interventi
Sponsors
National Institute of Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are clinically diagnosed with dermatophytosis. Patients of all gender, religion and all socioeconomic status. Patients 16 years to 70 years. Patients willing to give written informed consent to be included in study.
Exclusion criteria
Exclusion criteria: Complicated with other skin conditions-psoriasis, eczema, seborrheic dermatitis, pityriasis rosea, impetigo, lichen planus, discoid lupus erythematous, and drug induced skin lesions. Immune ? compromised state. Diagnosed cases of unstable mental or psychiatric illness and serious systemic disorders or life-threatening infections. Patient under the treatment of any other therapy for dermatophytosis for last one month. Patients who are unwilling to for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy between a single dose and multiple of 50 millesimal scale individualized homeopathic medicines in treatment of dermatophytosis using the dermatological life quality index. duration of study 18 months and first investigation from baseline after 6 months.Timepoint: duration of study 18 months and first investigation from baseline after 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr NIKAM ANKITA SHIVAJI
National Institute of Homoeopathy
Outcome results
None listed